van der Kolk DM - Search Results

1

Variation in mutation spectrum partly explains regional differences in the breast cancer risk of female BRCA mutation carriers in the Netherlands.

Vos JR, Teixeira N, van der Kolk DM, Mourits MJ, Rookus MA, van Leeuwen FE, Collée M, van Asperen CJ, Mensenkamp AR, Ausems MG, van Os TA, Meijers-Heijboer HE, Gómez-Garcia EB, Vasen HF, Brohet RM; Hereditary Breast and Ovarian Cancer Research Group Netherlands; van der Hout AH, Jansen L, Oosterwijk JC, de Bock GH. Vos JR, et al. Among authors: van der kolk dm. Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2482-91. doi: 10.1158/1055-9965.EPI-13-1279. Epub 2014 Aug 7. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 25103822

2

Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.

van der Kolk DM, de Bock GH, Leegte BK, Schaapveld M, Mourits MJ, de Vries J, van der Hout AH, Oosterwijk JC. van der Kolk DM, et al. Breast Cancer Res Treat. 2010 Dec;124(3):643-51. doi: 10.1007/s10549-010-0805-3. Epub 2010 Mar 4. Breast Cancer Res Treat. 2010. PMID: 20204502

3

Breast Cancer Incidence After Risk-Reducing Salpingo-Oophorectomy in BRCA1 and BRCA2 Mutation Carriers.

Fakkert IE, Mourits MJ, Jansen L, van der Kolk DM, Meijer K, Oosterwijk JC, van der Vegt B, Greuter MJ, de Bock GH. Fakkert IE, et al. Among authors: van der kolk dm. Cancer Prev Res (Phila). 2012 Nov;5(11):1291-7. doi: 10.1158/1940-6207.CAPR-12-0190. Epub 2012 Sep 25. Cancer Prev Res (Phila). 2012. PMID: 23009828

4

Proven non-carriers in BRCA families have an earlier age of onset of breast cancer.

Vos JR, de Bock GH, Teixeira N, van der Kolk DM, Jansen L, Mourits MJ, Oosterwijk JC. Vos JR, et al. Among authors: van der kolk dm. Eur J Cancer. 2013 Jun;49(9):2101-6. doi: 10.1016/j.ejca.2013.02.018. Epub 2013 Mar 13. Eur J Cancer. 2013. PMID: 23490645 Free article.

5

Maximising the efficiency of clinical screening programmes: balancing predictive genetic testing with a right not to know.

Schuurman AG, van der Kolk DM, Verkerk MA, Birnie E, Ranchor AV, Plantinga M, van Langen IM. Schuurman AG, et al. Among authors: van der kolk dm. Eur J Hum Genet. 2015 Sep;23(9):1124-8. doi: 10.1038/ejhg.2014.269. Epub 2015 Jan 7. Eur J Hum Genet. 2015. PMID: 25564039 Free PMC article.

6

The role of breast cancer resistance protein in acute lymphoblastic leukemia.

Plasschaert SL, van der Kolk DM, de Bont ES, Kamps WA, Morisaki K, Bates SE, Scheffer GL, Scheper RJ, Vellenga E, de Vries EG. Plasschaert SL, et al. Among authors: van der kolk dm. Clin Cancer Res. 2003 Nov 1;9(14):5171-7. Clin Cancer Res. 2003. PMID: 14613996

7

Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines.

Scheffer GL, Maliepaard M, Pijnenborg AC, van Gastelen MA, de Jong MC, Schroeijers AB, van der Kolk DM, Allen JD, Ross DD, van der Valk P, Dalton WS, Schellens JH, Scheper RJ. Scheffer GL, et al. Among authors: van gastelen ma, van der valk p, van der kolk dm. Cancer Res. 2000 May 15;60(10):2589-93. Cancer Res. 2000. PMID: 10825126

8

Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia.

Plasschaert SL, de Bont ES, Boezen M, vander Kolk DM, Daenen SM, Faber KN, Kamps WA, de Vries EG, Vellenga E. Plasschaert SL, et al. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8661-8. doi: 10.1158/1078-0432.CCR-05-1096. Clin Cancer Res. 2005. PMID: 16361551

9

P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.

van der Kolk DM, de Vries EG, van Putten WJ, Verdonck LF, Ossenkoppele GJ, Verhoef GE, Vellenga E. van der Kolk DM, et al. Among authors: van putten wj. Clin Cancer Res. 2000 Aug;6(8):3205-14. Clin Cancer Res. 2000. PMID: 10955805

10

Activity and expression of the multidrug resistance proteins MRP1 and MRP2 in acute myeloid leukemia cells, tumor cell lines, and normal hematopoietic CD34+ peripheral blood cells.

van der Kolk DM, de Vries EG, Koning JA, van den Berg E, Müller M, Vellenga E. van der Kolk DM, et al. Among authors: van den berg e. Clin Cancer Res. 1998 Jul;4(7):1727-36. Clin Cancer Res. 1998. PMID: 9676848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page